COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management.

View OpEd: https://www.infectioncontroltoday.com/view/covid-19-realities-beyond-a-respiratory-virus-addressing-optimism-in-pandemic-management

References:

1. Adalja A. When It Comes to Isolation, COVID Shouldn't Be Singled Out From the Pack.MedPage Today. 2024 Feb. 20, 2024. https://www.medpagetoday.com/opinion/second-opinions/108817

2. Sutherland S. Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments. Scientific America. 2023 March 1, 2023. https://www.unmc.edu/healthsecurity/transmission/2023/02/14/long-covid-now-looks-like-a-neurological-disease-helping-doctors-to-focus-treatments/

3. Merschel M. Beyond breathing: How COVID-19 affects your heart, brain and other organs. American Heart Association News. 2024 January 16, 2024. https://www.heart.org/en/news/2024/01/16/how-covid-19-affects-your-heart-brain-and-other-organs

4. Xie Y, Choi T, Al-Aly Z. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. Lancet Infect Dis. 2023. https://pubmed.ncbi.nlm.nih.gov/38104583/

5. Link-Gelles R, Ciesla AA, Mak J, Miller JD, Silk BJ, Lambrou AS, et al. Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024. MMWR Morb Mortal Wkly Rep. 2024;73(4):77-83. https://pubmed.ncbi.nlm.nih.gov/38300853/

6. Marra AR, Kobayashi T, Callado GY, Pardo I, Gutfreund MC, Hsieh MK, et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e168. https://pubmed.ncbi.nlm.nih.gov/38028898/

7. Elliott L. Record long-term sickness bodes ill for UK economic growth. The Guardian. 2024. https://www.theguardian.com/business/2024/feb/17/record-long-term-sickness-bodes-ill-for-uk-economic-growth

8. Bach K. New data shows long Covid is keeping as many as 4 million people out of work [Internet]. 2022. Available from: https://www.brookings.edu/articles/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work/.

9. Gruber R, Montilva Ludewig MV, Wessels C, Schlang G, Jedhoff S, Herbrandt S, Mattner F. Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors. BMC Infect Dis. 2024;24(1):119. https://pubmed.ncbi.nlm.nih.gov/38262969/

10. COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data. 2023. https://www.healthwatchusa.org/downloads/20230611-covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf

11. COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting. 2022. https://www.healthwatchusa.org/downloads/20221215-covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf

12. Davis M. Typical US Hospital Stay Costs 384 Hours of Work With Average Earnings. Value Penguin. 2023 Oct. 16, 2023. https://www.valuepenguin.com/hospital-bill-costs-study

13. Wang L, Davis PB, Berger N, Kaelber DC, Volkow N, Xu R. Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study. Fam Med Community Health. 2023;11(4). https://pubmed.ncbi.nlm.nih.gov/37832975/

14. Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210-6. https://pubmed.ncbi.nlm.nih.gov/35027728/

15. Sweden TPHAo. Current weekly report on RS virus: The Public Health Agency of Sweeden; 2023 [Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistik-a-o/sjukdomsstatistik/rsv-veckorapporter/aktuell-veckorapport-om-rsv/

16. Croda J. Exploring the potential benefits of mucosal COVID-19 vaccines: opportunities and challenges. Lancet Infect Dis. 2023;23(10):1099-100. https://pubmed.ncbi.nlm.nih.gov/37352881/

17. Heilmann E, Costacurta F, Moghadasi SA, Ye C, Pavan M, Bassani D, et al. SARS-CoV-2 3CL(pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Sci Transl Med. 2023;15(678):eabq7360. https://pubmed.ncbi.nlm.nih.gov/36194133/

18. Tita B. The U.S. Invested Millions to Produce Masks at Home. Now Nobody’s Buying. Wall Street Journal. 2024 Feb. 4, 2024. https://www.wsj.com/health/healthcare/the-u-s-invested-millions-to-produce-masks-at-home-now-nobodys-buying-fee1c49f